Pharming Group NV (PHARM) — Capital Reinvestment Ratio
Pharming Group NV (PHARM) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow (€32.03 Million) in capital expenditures (€70.00K). Check PHARM intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pharming Group NV Capital Reinvestment Ratio (2017–2022)
This chart tracks Pharming Group NV's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Pharming Group NV.
Annual Capital Reinvestment Ratio for Pharming Group NV (2017–2022)
Year-by-year Capital Reinvestment Ratio for Pharming Group NV from 2017 to 2022. See cash generation quality of Pharming Group NV to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.09x | €22.90 Million | €1.98 Million | ▼ -80.5% |
| 2021 | 0.44x | €36.13 Million | €15.96 Million | ▲ +144.0% |
| 2020 | 0.18x | €90.98 Million | €16.47 Million | ▼ -47.0% |
| 2019 | 0.34x | €74.56 Million | €25.44 Million | ▲ +265.6% |
| 2018 | 0.09x | €46.19 Million | €4.31 Million | ▼ -41.0% |
| 2017 | 0.16x | €45.84 Million | €7.25 Million | — |